A Phase 1 Open-Label, Dose-Escalation Study Evaluating The Safety, Tolerability, And Pharmacokinetics Of Enzalutamide (Previously Mdv3100) Alone Or In Combination With An Aromatase Inhibitor In Women With Advanced Breast Cancer
CANCER RESEARCH(2013)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined